Axess Vision Technology Explained

Axess Vision Technology Ltd
Type:Privately held
Fate:Acquired (2017)
Location:Tours
Key People:Regis Olivier, General Manager
Industry:Medical technology
Owner:The Surgical Company (TSC) Group
Num Employees:18
Products:Medical devices
Foundation:2006

Axess Vision Technology is a start-up company and manufacturer of medical devices, mainly endoscopes. It is headquartered in Saint Pierre des Corps, France. It is competing with Ambu and Single Use Surgical Ltd to develop the world first generation of disposable endoscopes.[1] These companies are responding to a market need of getting rid of cross contamination from flexible endoscopes, the latter ranked third in the ECRI 2011 top 10 Health Hazards.[2] Even when endoscopes are spotless, there remains a risk of infection of 1%. Therefore, these endoscopes are designed to be used on one patient only before being incinerated.[3]

Its main investors are the venture capitalists OTC Asset Management and Cap Décisif Management, with 2.5 million euros in the first round.[4] [5] [6] [7] Its main competitors are the German Invendo and the English Single Use Surgical.[8] The problematic decontamination of reusable endoscopes and the risk of nosocomial infections seems to have prompted this race for innovation.[9] Indeed, even if traditional endoscopes are cleaned and decontaminated after use, there is always a risk of infection of about 1%. The endoscopes developed by Axess Vision Technology are therefore designed to be used once before being incinerated.[10] [11]

In 2014, a contract was signed with the University Hospital of Rennes.[12]

On February 7, 2017, the company was placed in safeguard proceedings.[13] In the same year, Axess Vision Technology SAS was acquired by The Surgical Company (TSC) Group.[14] [15]

See also

External links

Notes and References

  1. Brosky . John . 2009 . Three EU companies vying to launch single use endoscope . Medical Device Daily . 13 .
  2. Web site: Archived copy . 2011-04-20 . dead . https://web.archive.org/web/20110724160457/https://www.ecri.org/Forms/Documents/Top_10_Health_Tech_Hazards_2011.pdf . 2011-07-24 .
  3. 2011. 100 start up où investir santé et biologie. Challenges. 256. 2011-05-13 .
  4. http://www.cdcentreprises.fr/images/actu_fonds/cap_decisif_avt_29_10_08.pdf Axess Vision Technology lève 2,5 M€ auprès d'OTC Asset Management et de Cap Decisif Management
  5. http://www.capdecisif.com/index.php?option=com_content&view=article&id=3&Itemid=4&lang=en Portfolio: Life Sciences - Medical Devices
  6. http://www.cdcentreprises.fr/portefeuille/fiche/fonds_directs/A268/cap%20decisif%202.php Cap Decisif 2
  7. fr. J. R. L'endoscope d'AVT recueille €2,5 M. Capital Finance. 908. 24 November 2008. 3.
  8. John. Brosky. Three EU companies vying to launch single use endoscope. Medical Device Daily. 13. 16 January 2009.
  9. HP. Gamble. Endoscope decontamination incidents in England 2003-2004. J Hosp Infect. 2007 . 4. 67. 350–354. 10.1016/j.jhin.2007.08.017 . 18023923.
  10. fr. Santé et Biotechnologies. Challenges. 256. 12 May 2011. 13 May 2011.
  11. Web site: January 26, 2016 . Avec son endoscope jetable Axess Vision voit loin . 2019-02-15 . lanouvellerepublique.fr .
  12. Web site: 2014-12-26 . Succès de l'endoscope jetable d'Axess Vision . 2022-07-22 . Les Echos . fr.
  13. Web site: AXESS VISION TECHNOLOGY (JOUE-LES-TOURS) Chiffre d'affaires, résultat, bilans sur SOCIETE.COM - 488295759 . 2022-07-22 . www.societe.com.
  14. Web site: 2006 . About us . 2024-01-19 . Endovision . en-GB.
  15. Web site: David . Bastien . 19 July 2022 . Joué-lès-Tours: an SME at the forefront of innovation . 19 January 2024 . la Nouvelle République . fr.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Axess Vision Technology".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.